BioNTech SE (BNTX)
| Market Cap | 80.87B |
| Revenue (ttm) | 588.20M |
| Net Income (ttm) | 18.53M |
| Shares Out | 242.52M |
| EPS (ttm) | 18.14 |
| PE Ratio | 18.39 |
| Forward PE | 8.24 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,603,105 |
| Open | 350.00 |
| Previous Close | 352.99 |
| Day's Range | 332.40 - 352.99 |
| 52-Week Range | 61.27 - 464.00 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 112.62 (-66.2%) |
| Est. Earnings Date | Nov 9, 2021 |
About BNTX
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116 for non-small ce...
Analyst Forecast
According to 10 analysts, the average rating for BioNTech SE stock is "Buy." The 12-month stock price forecast is 112.62, which is a decrease of -66.23% from the latest price.
News
CDC approves Covid booster shots for those over 65
Anjalee Khemlani joins Yahoo Finance to break down the CDC's decision to support boosters for at-risk workers, vulnerable Americans, and seniors as surges of COVID continue to grip the nation. Don't Mis...
CDC director endorses Pfizer booster for frontline workers, overruling advisory panel
The decision is in line with FDA authorization for booster shots of the Pfizer-BioNTech vaccine.
CDC director overrules advisors, expands booster recommendation
CNBC's Meg Tirrell reports on CDC director overruling advisers to expand Covid vaccine booster recommendation.
Pfizer/BioNTech COVID-19 Boosters For Seniors, Certain Vulnerable Adults Coming Soon - CDC Panel Recommends
The Centers for Disease Control and Prevention (CDC) backed a booster shot of Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine for Americans aged 65 and older and adults with an un...
CDC Director Backs Pfizer Booster Shots For Seniors, Vulnerable—And High-Risk Workers
Dr. Rochelle Walensky recommended workers in high-risk settings to also be offered Pfizer Covid booster doses, despite the CDC advisers voting against this group getting the third shot.
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging update in coronavirus vaccine.
Why BioNTech Thrashed the Market on Thursday
With its latest ruling on the biotech's coronavirus vaccine, the FDA boosts the investment case for the stock.
CDC advisors vote to recommend Pfizer booster
Meg Tirrell joins Closing Bell with breaking news from a CDC advisory panel evaluating Covid booster shots.
CDC panel recommends Pfizer booster for some people
Pfizer recipients 65 and older and those living in long-term care facilities would be eligible for a booster. People ages 18 to 64 with an underlying health condition would be eligible too.
CDC panel endorses Pfizer Covid booster shots for people 65 and older
Pfizer (PFE) Booster Dose Gets FDA Nod for High-Risk People
FDA approves Pfizer's (PFE) COVID-19 vaccine booster shots for older adults and high-risk people amid rising infection rates in the country.
EMA To Decide On Pfizer/BioNTech COVID-19 Booster Next Month: Reuters
The European Medicines Agency (EMA) expects to decide on the authorization for Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) COVID-19 booster shot at the beginning of October, Reuters reported cit...
Pfizer COVID-19 Vaccine Booster Shot Approved By FDA For High-Risk Individuals, People 65 And Up
The U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer Inc. (NYSE: PFE)-BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine for people aged 65 years and older as well as othe...
FDA Authorizes Pfizer Covid Booster Shots For Seniors And High-Risk Patients — But Not For All Americans
The FDA greenlit a third dose of Pfizer's coronavirus vaccine for seniors, people with underlying health conditions and people with “occupational exposure” to the coronavirus.
FDA authorizes Pfizer's Covid booster shots for people 65 and older and other vulnerable Americans
The CDC's vaccine advisory committee plans to meet this week, and the agency's panel of experts is expected to vote on plans to distribute third shots.
BioNTech SE Sponsored ADR (BNTX) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, BioNTech SE Sponsored ADR (BNTX) closed at $339.26, marking a -0.61% move from the previous day.
US to donate 500m extra vaccine shots - as Biden tells rich nations to share 'with no strings attached'
The US is buying a further 500 million COVID-19 vaccine doses to donate to other countries, bringing its total commitment to over a billion jabs, President Joe Biden has announced.
Pfizer CEO on providing 500 million vaccines to low income countries
CNBC's "Squawk Box" team discusses the coronavirus vaccine and how it can get to lower income countries to provide equitable access and infrastructure with Pfizer CEO Albert Bourla.
U.S. To Donate 500 Million More Pfizer Vaccine Doses To Poorer Countries
The deal doubles the country's existing commitment and brings the total number of doses it says it will share to 1 billion.
US To Donate Additional 500M Pfizer-BioNTech COVID-19 Vaccine Doses To Lower Income Nations
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) will provide the U.S. government additional 500 million doses of its COVID-19 vaccine. The doses at a not-for-profit price will be used for donation...
U.S. to donate millions more Pfizer-BioNTech vaccine doses to poorer nations
Pfizer and BioNTech will provide an additional 500 million doses of their Covid-19 vaccine to the U.S. government to be donated to lower income countries.
Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-Fo...
NEW YORK and MAINZ, Germany, September 22, 2021— Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced plans to expand their agreement with the U.S. government by ...
FDA To Probably Decide On Pfizer/BioNTech COVID-19 Booster Shots By Tomorrow: Bloomberg
Citing people familiar with the matter, Bloomberg reports that the FDA is expected to decide on Wednesday whether to recommend Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine as a...
For BioNTech, the COVID-19 vaccine was simply the opening act
Ultimately, BioNTech's mission is to make treatments that are optimized not only to specific patient needs, but also to time and place.
2 Outperforming Biotech Stocks to Examine on Covid-19 Vaccine Updates
With recent updates from Pfizer Inc. ( PFE , Financial) and BioNTech SE ( BNTX , Financial) regarding the effectiveness of their Covid-19 vaccine among children ages 5 to 11 and Johnson & Johnson's ( JN...